Surgery Partners, Inc. (NASDAQ:SGRY) Receives Average Rating of “Moderate Buy” from Analysts

Shares of Surgery Partners, Inc. (NASDAQ:SGRY) have received an average rating of “Moderate Buy” from the nine brokerages that are presently covering the company, MarketBeat Ratings reports. Two analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 1-year target price among analysts that have updated their coverage on the stock in the last year is $39.63.

SGRY has been the subject of several recent research reports. KeyCorp began coverage on shares of Surgery Partners in a research report on Friday, October 11th. They set a “sector weight” rating for the company. Cantor Fitzgerald reiterated an “overweight” rating and issued a $43.00 price target on shares of Surgery Partners in a research report on Friday, October 4th. Macquarie began coverage on shares of Surgery Partners in a research report on Friday, June 28th. They issued an “outperform” rating and a $31.00 price target for the company. UBS Group began coverage on shares of Surgery Partners in a research report on Monday, October 14th. They issued a “buy” rating and a $38.00 price target for the company. Finally, StockNews.com lowered shares of Surgery Partners from a “hold” rating to a “sell” rating in a research report on Wednesday, August 7th.

Surgery Partners Stock Performance

Shares of NASDAQ SGRY opened at $30.87 on Friday. The firm has a 50 day moving average of $31.26 and a 200 day moving average of $28.05. The company has a current ratio of 1.83, a quick ratio of 1.69 and a debt-to-equity ratio of 0.96. The firm has a market capitalization of $3.92 billion, a price-to-earnings ratio of -114.33, a price-to-earnings-growth ratio of 2.45 and a beta of 2.75. Surgery Partners has a 12-month low of $22.05 and a 12-month high of $36.92.

Surgery Partners (NASDAQ:SGRY) last announced its earnings results on Tuesday, August 6th. The company reported $0.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.20 by $0.01. The company had revenue of $762.10 million during the quarter, compared to analyst estimates of $735.94 million. Surgery Partners had a negative net margin of 1.17% and a positive return on equity of 2.96%. The firm’s quarterly revenue was up 14.2% compared to the same quarter last year. During the same period in the previous year, the business posted $0.25 earnings per share. On average, research analysts anticipate that Surgery Partners will post 0.84 earnings per share for the current year.

Hedge Funds Weigh In On Surgery Partners

Hedge funds and other institutional investors have recently modified their holdings of the stock. Arizona State Retirement System raised its stake in Surgery Partners by 1.9% during the second quarter. Arizona State Retirement System now owns 19,494 shares of the company’s stock valued at $464,000 after purchasing an additional 359 shares in the last quarter. Mackenzie Financial Corp raised its stake in Surgery Partners by 3.4% during the second quarter. Mackenzie Financial Corp now owns 19,999 shares of the company’s stock valued at $476,000 after purchasing an additional 662 shares in the last quarter. ProShare Advisors LLC raised its stake in Surgery Partners by 7.8% during the first quarter. ProShare Advisors LLC now owns 13,588 shares of the company’s stock valued at $405,000 after purchasing an additional 986 shares in the last quarter. Natixis Advisors LLC raised its stake in Surgery Partners by 11.0% during the second quarter. Natixis Advisors LLC now owns 12,452 shares of the company’s stock valued at $296,000 after purchasing an additional 1,237 shares in the last quarter. Finally, DekaBank Deutsche Girozentrale raised its stake in Surgery Partners by 102.0% during the first quarter. DekaBank Deutsche Girozentrale now owns 2,723 shares of the company’s stock valued at $80,000 after purchasing an additional 1,375 shares in the last quarter.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.